suliqua
sanofi winthrop industrie - glargininsuliini, lixisenatide - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
litalgin 500 mg/ml + 2 mg/ml injektioneste, liuos
takeda oy - metamizole sodium, pitofenone hydrochloride - injektioneste, liuos - 500 mg/ml + 2 mg/ml - pitofenoni ja analgeetti
litalgin 1 g / 10 mg peräpuikko
takeda oy takeda oy - beta-dimethyl-aminoethylbenzilati hydrochloridum,metamizolum natricum,pitofenoni hydrochloridum - peräpuikko - 1 g / 10 mg - pitofenoni ja analgeetti
litalgin 500 mg / 5 mg tabletti
takeda oy - metamizole sodium, pitofenone hydrochloride - tabletti - 500 mg / 5 mg - pitofenoni ja analgeetti
metronidazol baxter 5 mg/ml infuusioneste, liuos
baxter holding b.v. - metronidazolum - infuusioneste, liuos - 5 mg/ml - metronidatsoli
pantoprazol actavis 40 mg enterotabletti
actavis group ptc ehf - pantoprazole - enterotabletti - 40 mg - pantopratsoli
malaseb vet. 20 mg/ml + 20 mg/ml shampoo
dechra veterinary products a/s - chlorhexidine digluconate, miconazole nitrate - shampoo - 20 mg/ml + 20 mg/ml
pramipexole sandoz 0.26 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 0.26 mg - pramipeksoli
pramipexole sandoz 0.52 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 0.52 mg - pramipeksoli
pramipexole sandoz 1.05 mg depottabletti
sandoz a/s sandoz a/s - pramipexolum dihydrochloridum monohydricum - depottabletti - 1.05 mg - pramipeksoli